Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,153,549
-
Total 13F shares
-
521,013
-
Share change
-
+119,941
-
Total reported value
-
$389,305
-
Price per share
-
$0.75
-
Number of holders
-
19
-
Value change
-
-$15,598
-
Number of buys
-
9
-
Number of sells
-
9
Institutional Holders of AETHLON MEDICAL INC - Common Stock (AEMD) as of Q3 2025
As of 30 Sep 2025,
AETHLON MEDICAL INC - Common Stock (AEMD) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
521,013 shares.
The largest 10 holders included
Ikarian Capital, LLC, HRT FINANCIAL LP, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Scientech Research LLC, TWO SIGMA INVESTMENTS, LP, XTX Topco Ltd, TWO SIGMA SECURITIES, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Tower Research Capital LLC (TRC).
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.